Lumanity

Therapeutic Science and Strategy

Science EN ↓ 27 episodes

In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.

Author

Lumanity

Category

Science

Podcast website

sites.libsyn.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

CAR-T in Solid Tumors: A Cancer Progress Sneak Peek 25.04.2022

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this second episode, Joel sits down with  Shivani Srivastava, PhD, Assistant Professor Human Biology Division, Fred Hutchinson Cancer Research Center , to explore: Key challenges to addressing solid tumors with cell therapy Recent developments (technology, scientifi...

Not So Rare: Win-wins in Ultra-orphan Diseases 25.02.2022

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this first episode, Joel sits down with Michael Parisi, CEO of Guidemark, and Michael Rice, Vice President, Head of Advanced Therapeutics, to explore: How uncovering NSCLC and SMA genetics led to record-speed options for patients with rare subtypes How the patient a...

Listen to the Therapeutic Science and Strategy podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.